By Marianna Wharry | December 21, 2023
In a blog post for Google, Wilson White, vice president of government affairs and public policy, wrote that the tech company is pleased with the results of the case. His post maintains that that settlement will "[build] on Android's choice and flexibility, [maintain] strong security protections, [retain] Google's ability to compete with other OS makers and [will] invest in the Android ecosystem for users and developers."
By Amanda O'Brien | December 20, 2023
The combination of Philadelphia-based Jefferson Health and Allentown Pennsylvania-based Lehigh Valley Health would host 30 hospitals and more than 62,000 employees spread across Pennsylvania and southern New Jersey.
By Maydeen Merino | December 19, 2023
FTC alleged purchase would have resulted in higher healthcare prices due to reduced competition.
By Maydeen Merino | December 18, 2023
"Fair, open, competitive markets have been essential to America's dynamic, thriving economy, and policing unlawful mergers is our front line of defense against harmful corporate consolidation," FTC Chair Lina Khan said.
By Ross Todd | December 15, 2023
Representing Epic Games, Gary Bornstein, Yonatan Even and Lauren Moskowitz of Cravath, Swaine & Moore convinced federal jurors in San Francisco that Google has an illegal monopoly on Android app distribution and in-app payments.
By Colleen Murphy | December 13, 2023
"Merck later admitted its lawsuit had no merit because it had failed to disclose prior art to the United States Patent and Trademark Office that would have resulted in the denial of patent protection for Zetia," the complaint said. "But simply by initiating the litigation, Merck triggered a 30-month stay, which precluded the Food & Drug Administration from granting final approval of Glenmark's ANDA."
New York Law Journal | Analysis
By Karen Hoffman Lent and Kenneth Schwartz | December 11, 2023
Antitrust developments in the health care and pharmaceutical industries were exceptionally active in 2023. From the FTC's challenge of a merger between Amgen and Horizon Therapeutics, to joint agency withdrawal of well-established health care merger policy statements, to agency interest in pharmacy benefit managers, the authors review some of the most notable antitrust activity in the health care and pharmaceutical industries over the past year.
By ALM Staff | December 11, 2023
This suit was surfaced by Law.com Radar. Read the complaint here.
By Lisa Willis | December 8, 2023
"This is a case that goes back 20 years, so the damages are substantial," said the Miami attorney representing the MDL
By Ross Todd | December 7, 2023
Williams & Connolly's trial-ready focus guides clients' toughest challenges.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS